Orange County Business Journal

Vita Reed covers healthcare, including health insurance, hospitals, medical devices and drug companies for the Orange County Business Journal. She can be reached at reed@ocbj.com.

Recent Stories

Can Valeant Keep It Up?

HEALTHCARE: Bid for Allergan looks light despite last week’s stir

Did Valeant Pharmaceuticals International Inc. make David Pyott’s point last week?

Device Maker Raises $25M for Stent

Irvine-based Ivantis Inc. said it raised $25 million in its second round of financing. It said it plans to use the money to support ongoing clinical trials for its Hydrus microstent, which is implanted into the eye to treat glaucoma. Glaucoma is a major cause of blindness around the world.

House Votes Yet Again to Repeal Medical Device Tax

Senate Divided on Levy Meant to Boost Reform

One of the medical device industry’s favorite topics—repealing a federal tax on its companies’ revenues—has resurfaced yet again in Congress.

Tease photo

Mazzo Resigns From Microsemi’s Board

Aliso Viejo-based Microsemi Corp. said that James V. Mazzo has resigned from its board of directors.

Tease photo

Mazzo Added to Insider Trading Indictment

Veteran Orange County medical device executive James V. Mazzo was added to a federal grand jury indictment on insider trading charges, the Department of Justice said today.

Tease photo

Valeant Previews Q3, Changes Tone on Allergan

Canada-based Valeant Pharmaceuticals International Inc., which is attempting a hostile takeover of Irvine-based Allergan Inc., got a lift in early trading today after it released a preview of its results for the current quarter.

Tease photo

Avanir Selling $200 Million in Stock

Aliso Viejo-based Avanir Pharmaceuticals Inc. is offering $200 million of its shares to the general public.

Tease photo

Irvine Glaucoma Device Startup Raises $25 Million

Irvine-based Ivantis Inc. said today that it raised $25 million in its second round of financing.

Tease photo

WSJ: Allergan in Advanced Talks for Potential Salix Deal

Irvine-based Allergan Inc. is in advanced talks to buy Salix Pharmaceuticals Ltd. after turning down a buyout offer from Actavis PLC, according to a report today in the Wall Street Journal.

View of Allergan as Buyer Revived

HEALTHCARE: Pyott says no rush for deal ahead of Dec. 18 meeting

Potential deals are once again taking center stage as Irvine-based Allergan Inc. continues its fight to keep its independence.

More stories